A delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databases

Clinical and Experimental Rheumatology

Volumn 31, Issue SUPPL.76, 2013, Pages

  Coulter, Corinne ^a   Baron, Murray ^b   Pope, Janet ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Canadian scleroderma research group (CSRG); Cluster analysis; Delphi; Scleroderma; Scleroderma clinical trials consortium (SCTC); Ssc classification criteria

Indexed keywords

ANTITOPOISOMERASE I; CENTROMERE ANTIBODY; DNA TOPOISOMERASE; UNCLASSIFIED DRUG;

ARTICLE; CLUSTER ANALYSIS; CONSENSUS DEVELOPMENT; DATA BASE; DELPHI STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DYSPHAGIA; FINGER ULCER; FREQUENCY ANALYSIS; HUMAN; MEDICAL EXPERT; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLERODACTYLY; SCLERODERMA RESEARCH GROUP DATABASE; SENSITIVITY AND SPECIFICITY; SKIN DISEASE; SYSTEMIC SCLEROSIS; TELANGIECTASIA; VASODILATATION; CLASSIFICATION; CONSENSUS; DIAGNOSIS RELATED GROUP; ESOPHAGUS FUNCTION DISORDER; FACTUAL DATABASE; RHEUMATOLOGY; SKIN ULCER; STANDARD;

CLUSTER ANALYSIS; CONSENSUS; DATABASES, FACTUAL; DELPHI TECHNIQUE; DIAGNOSIS-RELATED GROUPS; ESOPHAGEAL MOTILITY DISORDERS; HUMANS; RAYNAUD DISEASE; RHEUMATOLOGY; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SKIN ULCER; TELANGIECTASIS;

EID: 84883795447     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. MASI AT, RODNAN G, MEDSGER T et al.: Preliminary criteria for the classification of systemic sclerosis [scleroderma]. Subcommittee for scleroderma criteria of the American Rheumatism Association. Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-90.
2. WALKER JG, POPE J, BARON M, et al.,: The development of Systemic Sclerosis classification criteria. Clin Rheumatol 2007; 26: 1401-9.
3. HUDSON M, TAILLEFER S, STEELE R, et al.,: Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007; 25: 754-7.
4. POPE JE, LEE P, BARON M, et al.,: Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. J Rheumatol 2005; 32: 1273-8.
5. BERNATSKY S, PANOPOLIS P, HUDSON M, et al.,; and the Canadian Scleroderma Research Group: Demographic and clinical factors associated with physician service use in systemic sclerosis. J Rheumatol 2009; 36: 96-8.
6. LeROY EC, BLACK C, FLEISCHMAJER R, et al.,: Scleroderma [systemic sclerosis]: classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
7. HUDSON M, THOMBS BD, STEELE R, et al.,: Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol 2009; 36: 768-72.
8. UEBERSAX JS: The tetrachoric and polychoric correlation coefficients. Statistical Methods for Rater Agreement. http://ourworld.compuserve.com/homepages/jsuebersax/tetra.htm. Updated 2006. Accessed 02/09, 2009.
9. SAS Institute Inc. SAS/STAT® User's Guide Version 8, The VARCLUS Procedure. http:// www.okstate.edu/sas/v8/saspdf/stat/chap68. pdf. Updated 2008. Accessed 03/09, 2009.
10. BELLIA M, CANNIZZARO F, SCICHILONE N, et al.,: HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities. Radiol Med 2009; 114: 190-203.
11. BOURNIA VK, VLACHOYIANNOPOULOS PG, SELMI C, MOUTSOPOULOS HM, GERSHWIN ME: Recent advances in the treatment of systemic sclerosis. Clin Rev Allergy Immunol 2009; 36: 176-200.
12. WIGLEY FM: Vascular disease in scleroderma. Clin Rev Allergy Immunol 2009; 36: 150-75.
13. LeROY EC, MEDSGER TA Jr.: Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
14. CUMMINGS SM, SAVITZ LA, KONRAD TR: Reported response rates to mailed physician questionnaires. Health Serv Res 2001; 35: 1347-55.
15. KILROY D, DRISCOLL P: Determination of required anatomical knowledge for clinical practice in emergency medicine: national curriculum planning using a modified Delphi technique. Emerg Med J 2006; 23: 693-6.
16. BOUTRON I, MOHER D, TUGWELL P, et al.,: A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT ) was developed using consensus. J Clin Epidemiol 2005; 58: 1233-40.
17. CHIA-CHIEN H, SANDFORD BA: The Delphi technique: making sense of consensus. Practical Assessment Research & Evaluation 2007; 12: 40.
18. AKINS RB, TOLSON H, COLE BR: Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol 2005; 5: 37.
19. SINGH JA, SOLOMON DH, DOUGADOS M, et al.,: Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006; 55: 348-52.
20. FELSON DT, ANDERSON JJ: Methodological and statistical approaches to criteria development in rheumatic diseases. Baillieres Clin Rheumatol 1995; 9: 253-66.
21. RUDWALEIT M, KHAN MA, SIEPER J: The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?. Arthritis Rheum 2005; 52: 1000-8.
22. TAYLOR W, GLADMAN D, HELLIWELL P, et al.,: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73.
23. FRIES JF, HOCHBERG MC, MEDSGER TA, Jr, HUNDER GG, BOMBARDIER C: Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1994; 37: 454-62.
24. LONZETTI LS, JOYAL F, RAYNAULD JP, et al.,: Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001; 44: 735-6.
25. NADASHKEVICH O, DAVIS P, FRITZLER MJ: A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 2004; 10: CR615-21.
26. HUDSON M, BARON M, Canadian Scleroderma Research Group (CSRG), STEELE R: Observational data to study medication outcomes in systemic sclerosis. J Rheumatol 2011; 38: 575-7.
27. FIANDER M, BURNS T: Essential components of schizophrenia care: a Delphi approach. Acta Psychiatr Scand 1998; 98: 400-5.
28. FRANSEN J, JOHNSON S, TYNDALL A, et al.,: Results of the Delphi for EULAR/ACR Classification Criteria Working Group in Systemic Sclerosis. In press. Arthritis Care Res 2012; 64: 351-7.
29. ZENG Y, LI M, XU D, et al.,: Macrovascular involvement in systemic sclerosis: evidence of correlation with disease activity. Clin Exp Rheumatol 2012; 30 (Suppl. 71): S76-80.
30. HARDING S, KHIMDAS S, BONNER A, BARON M, POPE J; Canadian Scleroderma Research Group: Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG). Clin Exp Rheumatol 2012; 30 (Suppl. 71): S38-43.
31. DISTLER JH, JORDAN S, AIRO P, ALEGRESANCHO JJ, ALLANORE Y, BALBIR GURMAN A: Is there a role for TNF-a antagonists in the treatment of SSc?. EUSTAR expert consensus development using the Delphi technique. Clin Exp Rheumatol 2011; 29 (Suppl. 65): S40-5.